Epidemiology of chronic hepatitis and cirrhosis in Turkey

More documents

Recommendations

Info

Projection of Lifetime Outcomesin HCV Infection100 acute HCV infections20% recovery20 patients80% persistent infections80 patients30% stable, chronic,nonprogressive40% variableprogression30% severeprogressive hepatitis24 patients32 patients 24 patientsAntiviral therapy56 patientsEnd-stage disease, HCC,liver transplantation,deathAdapted from Alter HF, Seeff LB. SeminLiver Dis. 2000;20:17-35.Treatmentfailure (50%)28 patientsSustainedresponse (50%)28 patients
Characteristic phases of CHB infectionImmunetoleranceImmuneclearanceImmunecontrolImmuneescapeHBeAg+veHBeAg–ve< > HBV-DNAALTHBeAg +vechronic hepatitisInactive (carrier)stateHBeAg –ve/+ve activechronic hepatitis
Page 1: Epidemiology of chronic hepatitis a
Page 5 and 6: ETIOLOGY OF HEPATOCELLULAR CARCINOM
Page 7 and 8: FULMINANT HEPATITIS IN TURKEYVIRAL
Page 9 and 10: Chronic Viral Hepatitis in the WEST
Page 11 and 12: Liver Cirrhosis in the WEST: Change
Page 13 and 14: Prevalence of delta hepatitis accor
Page 15 and 16: Change in delta hepatitis prevalenc
Page 17 and 18: MethodsEstablishing the patient coh
Page 19 and 20: Mathematic ModelMarkov SimulationSp
Page 21 and 22: Reults of a 20 year projection:Natu
Page 23 and 24: Liver-specific death rate in the CH
Page 25 and 26: Construction method of the patient
Page 27: Greetings from ISTANBUL

Epidemiology of chronic hepatitis and cirrhosis in Turkey

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?